Related Experiment Videos

Erlotinib: optimizing therapy with predictors of response?

Susan Goodin1

  • 1Pharmaceutical Sciences, The Cancer Institute of New Jersey and Division of Medical Oncology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08903-2681, USA. goodin@umdnj.edu

Summary

No abstract available in PubMed .

Related Concept Videos